Activity of faropenem against middle ear fluid pathogens from children with acute otitis media in Costa Rica and Israel

Kimberley Clawson Stone, Ron Dagan, Adriano Arguedas, Eugene Leibovitz, Elaine Wang, Roger M. Echols, Nebojsa Janjic, Ian A. Critchley

Research output: Contribution to journalArticlepeer-review

8 Scopus citations

Abstract

Faropenem was tested against 1,188 middle ear fluid pathogens from children in Israel and Costa Rica. Against Streptococcus pneumoniae and Haemophilus influenzae, faropenem was the most active β-lactam, with activity that was similar to or greater than of the other oral antimicrobial classes studied. Faropenem was also active against Moraxella catarrhalis and Streptococcus pyogenes.

Original languageEnglish
Pages (from-to)2230-2235
Number of pages6
JournalAntimicrobial Agents and Chemotherapy
Volume51
Issue number6
DOIs
StatePublished - 1 Jun 2007

ASJC Scopus subject areas

  • Pharmacology
  • Pharmacology (medical)
  • Infectious Diseases

Fingerprint

Dive into the research topics of 'Activity of faropenem against middle ear fluid pathogens from children with acute otitis media in Costa Rica and Israel'. Together they form a unique fingerprint.

Cite this